Peer Review reports
From: Inhibition of SMAD3 effectively reduces ADAMTS-5 expression in the early stages of osteoarthritis
Original Submission | ||
---|---|---|
10 May 2022 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
27 Jun 2022 | Reviewed | Reviewer Report |
8 Jul 2022 | Reviewed | Reviewer Report |
23 Jul 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 5 | ||
23 Jul 2022 | Submitted | Manuscript version 5 |
26 Jul 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 6 | ||
26 Jul 2022 | Submitted | Manuscript version 6 |
30 Jul 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 7 | ||
30 Jul 2022 | Submitted | Manuscript version 7 |
1 Aug 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 8 | ||
1 Aug 2022 | Submitted | Manuscript version 8 |
5 Aug 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 9 | ||
5 Aug 2022 | Submitted | Manuscript version 9 |
12 Aug 2022 | Reviewed | Reviewer Report |
30 Aug 2022 | Reviewed | Reviewer Report |
12 Sep 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 10 | ||
12 Sep 2022 | Submitted | Manuscript version 10 |
17 Sep 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 11 | ||
17 Sep 2022 | Submitted | Manuscript version 11 |
5 Oct 2022 | Reviewed | Reviewer Report |
30 Oct 2022 | Author responded | Author comments - Weishan Wang |
Resubmission - Version 12 | ||
30 Oct 2022 | Submitted | Manuscript version 12 |
3 Nov 2022 | Reviewed | Reviewer Report |
Resubmission - Version 13 | ||
Submitted | Manuscript version 13 | |
Publishing | ||
4 Nov 2022 | Editorially accepted | |
17 Feb 2023 | Article published | 10.1186/s12891-022-05949-8 |
You can find further information about peer review here.